Physician

John Thomas Chewning, M.D.

According to 2025 Medicare claims, John Chewning, M.D. (NPI: 1780798652) practices sleep medicine in the Winston-Salem, NC market, with the plurality of this provider's patient population coming from Forsyth, NC. This provider's primary affiliated billing organization is NOVANT HEALTH MEDICAL GROUP, LLC (NPI: 1912620030; TIN: 581728803) and primary practice location at 27103-6946. Chewning is affiliated with the Novant Health Accountable Care Organization I, LLC (ACO ID: A3504), participating under the MSSP model.

Chewning's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 496 traditional Medicare patients, billed 984 HCPCS/CPT codes, and received $60,467 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 571 prescription claims across 96 beneficiaries totaling $36,705 in drug costs, led by Sunosi (Solriamfetol Hcl). DME data shows 7,068 claims. Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $42,906 and ending at $36,705. For DME billing, reported payments rose steadily, from $384,058 to $351,934.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	540	841	$66,427
2016	467	842	$75,159
2017	452	847	$65,057
2018	523	872	$82,614
2019	576	1,075	$112,480
2020	536	855	$84,688
2021	546	794	$79,266
2022	561	763	$65,928
2023	527	765	$59,009
2024	496	984	$60,467

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	93	401	$42,906
2016	98	474	$82,970
2017	104	541	$54,845
2018	106	467	$24,486
2019	84	416	$183,623
2020	84	539	$214,443
2021	98	552	$39,466
2022	108	630	$48,088
2023	100	541	$55,756
2024	96	571	$36,705

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	2,769	5,717	$379,931
2016	3,291	6,340	$252,181
2017	3,604	7,128	$224,022
2018	3,573	7,455	$237,445
2019	3,647	7,492	$270,090
2020	3,099	6,121	$278,064
2021	2,857	6,137	$309,297
2022	2,919	6,694	$346,551
2023	2,830	6,939	$395,117
2024	2,946	7,068	$351,340

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	238	280	$84
95810	Sleep study in sleep lab (6 years or older)	97	97	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	122	134	$60
95806	Sleep study including heart rate, breathing, airflow, and effort	72	72	$32
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	161	185	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sunosi	Solriamfetol Hcl	19	570	$20,603
Armodafinil	Armodafinil	95	3,322	$4,370
Modafinil	Modafinil	43	1,567	$3,766
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	48	1,560	$1,223
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	75	5,790	$1,007

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	277	715	$67,793
A7030	Full face mask used with positive airway pressure device, each	N	287	720	$62,003
E0601	Continuous positive airway pressure (cpap) device	Y	209	1,174	$40,386
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	366	890	$33,958
A7032	Cushion for use on nasal mask interface, replacement only, each	N	112	274	$30,753

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$15	Inspire Medical Systems, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Thomas Chewning, M.D.?

Tedicare shows public-source Medicare data for John Thomas Chewning, M.D. (NPI 1780798652), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Thomas Chewning, M.D. have ACO affiliation data?

John Thomas Chewning, M.D. is shown with ACO affiliation data for Novant Health Accountable Care Organization I, LLC (MSSP, ACO ID A3504).

What billing organization is linked to John Thomas Chewning, M.D.?

John Thomas Chewning, M.D. is linked to NOVANT HEALTH MEDICAL GROUP, LLC (billing NPI 1912620030) in the available physician profile data.

Does John Thomas Chewning, M.D. have Open Payments data?

John Thomas Chewning, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.